A follow-up study of survivors of Rh-haemolytic disease.
D000293:Adolescent; D001663:Bilirubin / Q000032:analysis; D001724:Birth Weight; D001769:Blood; D002648:Child; D003638:Deafness / Q000209:etiology; D004410:Dyslexia / Q000209:etiology; D004899:Erythroblastosis, Fetal / Q000097:blood / Q000150:complications* / Q000628:therapy; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D005500:Follow-Up Studies; D006454:Hemoglobins / Q000097:blood; D006801:Humans; D007231:Infant, Newborn; D008607:Intellectual Disability / Q000209:etiology; D008297:Male; D009069:Movement Disorders / Q000209:etiology; D011225:Pre-Eclampsia / Q000150:complications; D011247:Pregnancy; D013064:Speech Disorders / Q000209:etiology; D014470:Umbilical Cord; D014786:Vision Disorders / Q000209:etiology; D014792:Visual Acuity
D006454:Hemoglobins; D001663:Bilirubin